France's National Agency for the Safety of Medicine and Health Products (ANSM) has ruled that the campaigns led by Novo Nordisk and Eli Lilly, which were presented as awareness initiatives, amounted to promotion of their products. Such advertising is forbidden in France.
AI Brief
Your highlights
A required part of this site couldn’t load. This may be due to a browser
extension, network issues, or browser settings. Please check your
connection, disable any ad blockers, or try using a different browser.